[1]
2013. The efficacy and toxicity of programs MOPP, ABVD, BEACOPP-base in primary Hodgkin’s lymphoma patients with a poor prognosis. Voprosy onkologii. 59, 2 (Dec. 2013), 59–65. DOI:https://doi.org/10.37469/0507-3758-2013-59-2-59-65.